Publications by authors named "O B Jorgensen"
Background: Interventional cardiac resynchronization therapy (I-CRT) for left ventricular lead (LVL) placement works as a supplement to traditional (over-the-wire) cardiac resynchronization therapy (T-CRT). It has been argued that I-CRT is a time-consuming and complicated procedure.
Objective: The purpose of this study was to investigate differences in procedure-related, perioperative, postoperative, and clinical endpoints between I-CRT and T-CRT.
Elevated FVIII levels in hereditary hemorrhagic telangiectasia: Implications for clinical management.
Laryngoscope Investig Otolaryngol
February 2024
Objectives: The objective of this study was twofold: to determine the prevalence of arterial and venous thromboembolic events in the Norwegian Hereditary Hemorrhagic Telangiectasia (HHT) population, and to explore potential factors linked to such events, with particular emphasis on FVIII.
Methods: Patients with an HHT diagnosis attending the Otorhinolaryngology Department at Oslo University Hospital-Rikshospitalet were included consecutively between April 2021 and November 2022. We recorded the participants' medical history with an emphasis on thromboembolic events.
Objectives: Thoracoscopic sympathicotomy may be an effective treatment for disabling facial blushing in selected patients. Short- and mid-term results are good but very long-term results are scarce in the medical literature and there is no knowledge which extent of sympathicotomy is better long-term for isolated facial blushing.
Methods: We previously randomized 100 patients between a rib-oriented R2 or R2-R3 sympathicotomy for isolated facial blushing, and reported local effects, side effects and quality of life after 12 months.
Article Synopsis
- The study evaluates the effectiveness and cost-efficiency of using an absorbable antibacterial envelope during cardiac device implantation to reduce infection rates in high-risk patients, contrasting it with traditional antibiotic treatments.
- Utilizing a decision-tree model and data from a Danish cohort study, it found that the antibacterial envelope resulted in a cost-effectiveness ratio of €12,022 per quality-adjusted life year (QALY), making it economically advantageous.
- The findings support its use in the Danish healthcare context and align with previous international studies, indicating potential for broader accessibility to this preventative technology in cardiac treatments.
Aims: Cardiac implantable electronic device (CIED) infection is a severe complication to modern management of cardiac arrhythmias. The CIED type and the type of surgery are recognized as risk factors for CIED infections, but knowledge of patient-related risk factors is scarce. This study aimed to identify lifelong patient-related risk factors for CIED infections.
View Article and Find Full Text PDF